… embryonic stem cells, human neural stem cells, human-induced pluripotent stem cells,
and … essential pathological processes and charactering single-cell changes in vitro. Furthermore, …

… of stem cells for therapy in Parkinson's disease. 1) Neural stem cells (NSCs) from human
fetal brain, expanded and differentiated to DA-ergic neurons; 2) Pluripotent cells generated …

… before stem cell-based therapies can … stem cells of four different sources: embryonic stem
cells from the fertilized egg, neural stem cells from the embryonic or adult brain, or from stem …

… has entered several disease entities including neurodegenerative disorders. Recent
clinical … DA) cells into the brain of Parkinson's disease (PD) patients can reduce disease-associated …

… development of stem-cell-based approaches. We also describe how far stem cells have got
… the major scientific and clinical problems to be solved for the successful application of stem …

… ’s disease symptoms in mouse and primate models. Here we discuss the history and implications
for cell therapy for Parkinson’s disease, … or halt the progression of Parkinson’s disease. …

… of novel cell replacement strategies based on the grafting of neural stem cells, and these
will be discussed here. In this review I will also focus on the use of neural stem cells to deliver …

… the vast obstacles that stem cell scientists have just begun to … using stem cell-derived products
for cell replacement therapy, … of stem cell therapy, focusing on Parkinson’s disease (PD). …

… Stem Cell Corporation’s (ISCO’s) approach to developing a pluripotent stem cell based treatment
for Parkinson’s disease (PD). … study of a pluripotent stem cell based therapy for PD. The …

… Parkinson’s disease is a common progressive neurodegenerative disorder caused by the
… We investigated whether cell therapy with human mesenchymal stem cells (hMSCs) had a …